Summary
Fluxion Biosciences Inc (Fluxion) is a provider of analytical and live cell analysis tools. The company’s products include IsoFlux system and CTC kits, BioFlux System, IonFlux System, Cytation CTC imager and enumeration kits, and sequencing kits. It provides analytical services for a range of circulating tumor cell and liquid biopsy applications. Fluxion's sequencing assays solutions provide ultra-sensitivity mutation detection from CTCs and cell-free DNA. The company serves biotech and pharmaceutical companies, academic institutions and government research organizations. It markets its products through a network of distributors in the US, Australia, New Zealand, China, Spain, France, Germany, Austria, India, Japan, Singapore, the Netherlands, Denmark and Iceland, among others. Fluxion is headquartered in South San Francisco, California, the US.
Fluxion Biosciences Inc - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Fluxion Biosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Fluxion Biosciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Fluxion Biosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Fluxion Biosciences Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Fluxion Biosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Fluxion Biosciences Inc, Medical Equipment, Deal Details 10
Partnerships 10
Fluxion Bioscience Forms Partnership with University of Texas Health Science Center 10
Fluxion Biosciences Enters into Co-Development Agreement with Stanford University School of Medicine 10
Fluxion Biosciences Enters Into Co-Development Agreement With Stanford University School of Medicine 11
Fluxion Bioscience Enters Into Technology Integration Agreement With Rubicon Genomics 12
Fluxion Biosciences Enters Into Distribution Agreement With EMD Millipore 13
Fluxion Biosciences Inc - Key Competitors 14
Key Employees 15
Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Product News 17
Oct 27, 2016: Fluxion Biosciences Launches Spotlight 59 NGS Oncology Panel For Liquid Biopsies 17
Sep 14, 2016: Fluxion Biosciences Launches IsoFlux Cytation Imager for Automated CTC Analysis 18
Mar 28, 2016: Fluxion Launches BioFlux Extended Flow Module 19
Mar 22, 2016: Fluxion Announced the Use of Its IonFlux Automated Patch Clamp System in the Discovery of Genentech GNE-0723, a Novel Drug Compound Suitable for In Vivo Characterization 20
Feb 17, 2016: Fluxion Biosciences Launches New Range of Circulating Tumor Cell (CTC) Recovery Kits- First Launch of Commercial Kits Targeting EMT Cells 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22List of Tables
Fluxion Biosciences Inc, Medical Equipment, Key Facts 1
Fluxion Biosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Fluxion Biosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Fluxion Biosciences Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Fluxion Biosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Fluxion Biosciences Inc, Deals By Market, 2011 to YTD 2017 8
Fluxion Biosciences Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Fluxion Bioscience Forms Partnership with University of Texas Health Science Center 10
Fluxion Biosciences Enters into Co-Development Agreement with Stanford University School of Medicine 10
Fluxion Biosciences Enters Into Co-Development Agreement With Stanford University School of Medicine 11
Fluxion Bioscience Enters Into Technology Integration Agreement With Rubicon Genomics 12
Fluxion Biosciences Enters Into Distribution Agreement With EMD Millipore 13
Fluxion Biosciences Inc, Key Competitors 14
Fluxion Biosciences Inc, Key Employees 15List of Figures
Fluxion Biosciences Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Fluxion Biosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Fluxion Biosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Fluxion Biosciences Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Fluxion Biosciences Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Fluxion Biosciences Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Fluxion Biosciences Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Fluxion Biosciences Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8
